Gentiopicroside ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting TLR4/NF-κB signaling in mice model. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 4, p. 135–145, 2022. DOI: 10.47750/pnr.2022.13.04.018. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/1445.. Acesso em: 17 jun. 2026.